1

2
Glover Francis James, Rushton Arthur, Young Stephen Clinton, Morgan Phillip John: Angiotensin derivatives. Proteus Molecular Design, December 15, 2004: EP1486505-A1

An angiotensin derivative comprising at least one angiotensin peptide moiety coupled to a peptide carrier-binding moiety which can be used for therapy and prophylaxis of conditions associated with the renin activated angiotensin system.


3
Glover James Francis, Rushton Arthur, Morgan Phillip John, Young Stephen Clinton: Derives dangiotensine, Angiotensin derivatives. Proteus Molecular Design, Proteus Molecular Design, Fetherstonhaugh & Co, December 15, 2009: CA2294996

An angiotensin derivative comprising at least one angiotensin peptide moiety coupled to a peptide carrier-binding moiety which canbe used for therapy and prophylaxis of conditions associated with the renin activated angiotensin system.


4
Liebeschuetz John Walter, Wylie William Alexander, Waszkowycz Bohdan, Murray Christopher William, Rimmer Andrew David, Welsh Pauline Mary, Jones Stuart Donald, Roscoe Jonathan Michael Ernest, Young Stephen Clinton, Morgan Phillip John, Camp Nicholas Paul, Crew Andrew Philip Austin: 1-amino-7-isoquinoline derivatives as serine protease inhibitors. Protherics Molecular Design Li, June 28, 2000: EP1012166-A1

The invention relates to serine protease inhibitor compound of formula (I), where R1 and R2 each independently is hydrogen or hydroxyl, alkoxyl, alkyl, aminoalkyl, hydroxyalkyl, alkoxyalkyl, alkoxycarbonyl, acyloxymethoxycarbonyl or alkylamino optionally substituted by hydroxy, alkylamino, alkoxy, o ...


5

6
Liebeschuetz John Walter, Young Stephen Clinton, Lively Sarah Elizabeth, Harrison Martin James, Waszkowycz Bohdan, Morgan Phillip John: Serine protease inhibitors. Tularik, Liebeschuetz John Walter, Young Stephen Clinton, Lively Sarah Elizabeth, Harrison Martin James, Waszkowycz Bohdan, Morgan Phillip John, HAY Martin A, December 21, 2000: WO/2000/077027

Compounds of formula (I) where R¿2?, each X, L, Y, Cy, Lp, D and n are as defined in the specification, are serine protease (especially tryptase) inhibitors useful as antiinflammatory agents.


7

8

9
Glover James Francis, Rushton Arthur, Morgan Phillip John, Young Stephen Clinton: Angiotensin derivatives. Proteus Molecular Design, Glover James Francis, Rushton Arthur, Morgan Phillip John, Young Stephen Clinton, GRANT Anne Rosemary, December 30, 1998: WO/1998/058952

An angiotensin derivative comprising at least one angiotensin peptide moiety coupled to a peptide carrier-binding moiety which can be used for therapy and prophylaxis of conditions associated with the renin activated angiotensin system.


10
Glover James Francis, Rushton Arthur, Morgan Phillip John, Young Stephen Clinton: Angiotensin derivatives. Proteus Molecular Design, May 24, 2000: EP1001978-A1

An angiotensin derivative comprising at least one angiotensin peptide moiety coupled to a peptide carrier-binding moiety which can be used for therapy and prophylaxis of conditions associated with the renin activated angiotensin system.